AstraZeneca AB & anr (appellants) v Glenmark Pharmaceuticals Europe Ltd (respondent)
Wednesday 9 November 2025
By Appellant’s Notice filed on 29 March 2025 and issued on 31 March 2025 the Applicant (Claimant below) AstraZeneca AB and AstraZeneca UK Ltd, seek to appeal the decision of Michael Tappin KC, sitting as a Deputy Judge of the High Court, judgment being delivered on 28 March 2025.
The High Court denied an interim injunction against Glenmark for alleged SPC infringement on dapagliflozin pending the outcome of a trial on the validity of AstraZeneca’s Supplementary Protection Certificates.
View hearing: